Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. / Celis, Julio E; Gromov, Pavel; Gromova, Irina; Moreira, José Manuel Alfonso; Cabezón, Teresa; Ambartsumian, Noona; Grigorian, Mariam; Lukanidin, Eugene; Thor Straten, Per; Guldberg, Per; Bartkova, Jirina; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia; Lykkesfeldt, Anne; Jäättelä, Marja; Roepstorff, Peter; Bolund, Lars; Ørntoft, Torben Falck; Brünner, Nils; Overgaard, Jens; Sandelin, Kerstin; Blichert-Toft, Mogens; Mouridsen, Henning; Rank, Fritz E.
In: Molecular and Cellular Proteomics, Vol. 2, No. 6, 2003, p. 369-377.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research
AU - Celis, Julio E
AU - Gromov, Pavel
AU - Gromova, Irina
AU - Moreira, José Manuel Alfonso
AU - Cabezón, Teresa
AU - Ambartsumian, Noona
AU - Grigorian, Mariam
AU - Lukanidin, Eugene
AU - Thor Straten, Per
AU - Guldberg, Per
AU - Bartkova, Jirina
AU - Bartek, Jiri
AU - Lukas, Jiri
AU - Lukas, Claudia
AU - Lykkesfeldt, Anne
AU - Jäättelä, Marja
AU - Roepstorff, Peter
AU - Bolund, Lars
AU - Ørntoft, Torben Falck
AU - Brünner, Nils
AU - Overgaard, Jens
AU - Sandelin, Kerstin
AU - Blichert-Toft, Mogens
AU - Mouridsen, Henning
AU - Rank, Fritz E
N1 - Kode for udgivelsesland: 'us' Kode for bibliotekets beholdning: 'modtaget'
PY - 2003
Y1 - 2003
N2 - The application of state-of-the-art proteomics and functional genomics technologies to the study of cancer is rapidly shifting toward the analysis of clinically relevant samples derived from patients, as the ultimate aim of translational research is to bring basic discoveries closer to the bedside. Here we describe the essence of a long-term initiative undertaken by The Danish Centre for Translational Breast Cancer Research and currently underway for cancer biomarker discovery using fresh tissue biopsies and bio-fluids. The Centre is a virtual hub that brings together scientists working in various areas of basic cancer research such as cell cycle control, invasion and micro-environmental alterations, apoptosis, cell signaling, and immunology, with clinicians (oncologists, surgeons), pathologists, and epidemiologists, with the aim of understanding the molecular mechanisms underlying breast cancer progression and ultimately of improving patient survival and quality of life. The unifying concept behind our approach is the use of various experimental paradigms for the prospective analysis of clinically relevant samples obtained from the same patient, along with the systematic integration of the biological and clinical data.
AB - The application of state-of-the-art proteomics and functional genomics technologies to the study of cancer is rapidly shifting toward the analysis of clinically relevant samples derived from patients, as the ultimate aim of translational research is to bring basic discoveries closer to the bedside. Here we describe the essence of a long-term initiative undertaken by The Danish Centre for Translational Breast Cancer Research and currently underway for cancer biomarker discovery using fresh tissue biopsies and bio-fluids. The Centre is a virtual hub that brings together scientists working in various areas of basic cancer research such as cell cycle control, invasion and micro-environmental alterations, apoptosis, cell signaling, and immunology, with clinicians (oncologists, surgeons), pathologists, and epidemiologists, with the aim of understanding the molecular mechanisms underlying breast cancer progression and ultimately of improving patient survival and quality of life. The unifying concept behind our approach is the use of various experimental paradigms for the prospective analysis of clinically relevant samples obtained from the same patient, along with the systematic integration of the biological and clinical data.
KW - Academies and Institutes
KW - Biomedical Research
KW - Biopsy
KW - Body Fluids
KW - Breast Neoplasms
KW - Denmark
KW - Electrophoresis, Gel, Two-Dimensional
KW - Female
KW - Gene Expression Profiling
KW - Genomics
KW - Humans
KW - Mammary Glands, Human
KW - Pilot Projects
KW - Proteomics
KW - Specimen Handling
KW - Tumor Markers, Biological
U2 - 10.1074/mcp.R300007-MCP200
DO - 10.1074/mcp.R300007-MCP200
M3 - Journal article
C2 - 12832461
VL - 2
SP - 369
EP - 377
JO - Molecular and Cellular Proteomics
JF - Molecular and Cellular Proteomics
SN - 1535-9476
IS - 6
ER -
ID: 7886834